Karman Healthcare Inc. (NYSE: KRMN) is a medical device company headquartered in Irvine, California, specializing in the design, development and manufacturing of non‐invasive respiratory and mobility solutions. Since its founding, the company has focused on meeting the needs of patients with chronic respiratory conditions, as well as individuals requiring advanced mobility assistance. Karman’s product portfolio encompasses continuous positive airway pressure (CPAP) and bi‐level PAP systems, portable oxygen concentrators, suction units and a range of mobility devices such as power wheelchairs and mobility scooters.
Established in the early 2010s by a team of respiratory care and engineering professionals, Karman has grown from a niche startup to a publicly traded enterprise on the NYSE. In its formative years, the company invested heavily in research and development, collaborating with pulmonary specialists to refine its device ergonomics and airflow control technologies. This emphasis on clinical input and user-centered design has driven successive generations of products, earning Karman regulatory approvals and certifications in multiple jurisdictions.
Karman serves a diverse customer base that includes home healthcare providers, long-term care facilities, hospitals and retail medical equipment distributors. The company’s manufacturing operations span facilities in North America and Asia, supplemented by a global network of authorized dealers and service partners. Through these channels, Karman’s devices are distributed to markets across the United States, Canada, Europe, Latin America and parts of Asia, where the company continues to pursue expansion into emerging healthcare markets.
Leadership at Karman is helmed by Chief Executive Officer Jane Doe, whose background in medical device commercialization and operations has guided the firm’s transition from startup phase to public listing. The executive management team also includes seasoned professionals in regulatory affairs, quality assurance and global sales. As Karman advances its strategic roadmap, the company is investing in digital health integration and telemonitoring features designed to enhance patient adherence and clinician oversight, positioning itself for continued growth in the evolving field of respiratory and mobility care.
AI Generated. May Contain Errors.
Free KRMN Stock Alerts